Résultats de la recherche - 8 results

neoplasia (CIN) and cancer; treating cervical abnormalities and cancer; and vaccinating women treated for CIN2 /3 to prevent recurrence. Evaluations will be performed using a simulation model, Policy1-Cervix ...

literature. Rates of knee-high immobilisation were high and immobilisation durations were short. However, it seems that the short immobilisation duration was paralleled by a high recurrence rate. This finding ...

knowledge gaps and areas for further research. RESULTS: HPV testing is sensitive for the detection of residual or recurrent disease post treatment for CIN2 + and is more sensitive than cytology alone. ...

conservative treatment of cervical pre-cancer, HPV testing picks up more quickly, with higher sensitivity and not lower specificity, residual or recurrent high-grade CIN than follow-up cytology. Primary ...

cases of cancer of the cervix, vulva, vagina, anus and oropharynx annually, as well as benign diseases such as genital warts and recurrent respiratory papillomatosis. Whereas the incidence of cervical ...

a significantly lower specificity compared to a repeat Pap smear. After treatment of cervical lesions, HPV testing easily detects (with higher sensitivity and not lower specificity) residual or recurrent CIN than ...

with ASCUS or LSIL. We also performed meta-analyses to examine the best predictor of recurrence of CIN after treatment for CIN2 or CIN3. RESULTS: We found that HPV testing using the Hybrid Capture II ...

A recurrent issue concerns the sustainability of primary prevention actions. A vicious circle exists due to the difficulty in measuring short-term impacts, which in turn, does not provide support for the ...